ZA891052B - Novel compounds - Google Patents

Novel compounds

Info

Publication number
ZA891052B
ZA891052B ZA891052A ZA891052A ZA891052B ZA 891052 B ZA891052 B ZA 891052B ZA 891052 A ZA891052 A ZA 891052A ZA 891052 A ZA891052 A ZA 891052A ZA 891052 B ZA891052 B ZA 891052B
Authority
ZA
South Africa
Prior art keywords
alkyl
hydrogen
group
chem
optionally substituted
Prior art date
Application number
ZA891052A
Other languages
English (en)
Inventor
Vittorio Vecchietti
Vecchietti Vittorio
Antonio Giordani
Giordani Antonio
Original Assignee
Zambeletti Spa L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambeletti Spa L filed Critical Zambeletti Spa L
Publication of ZA891052B publication Critical patent/ZA891052B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
ZA891052A 1988-02-12 1989-02-10 Novel compounds ZA891052B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888803259A GB8803259D0 (en) 1988-02-12 1988-02-12 Compounds

Publications (1)

Publication Number Publication Date
ZA891052B true ZA891052B (en) 1991-03-27

Family

ID=10631593

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA891052A ZA891052B (en) 1988-02-12 1989-02-10 Novel compounds

Country Status (14)

Country Link
US (1) US4994450A (de)
EP (1) EP0333315B1 (de)
JP (1) JPH01246258A (de)
KR (1) KR890012963A (de)
AT (1) ATE64391T1 (de)
AU (1) AU615984B2 (de)
DE (1) DE68900113D1 (de)
DK (1) DK65489A (de)
ES (1) ES2039845T3 (de)
GB (1) GB8803259D0 (de)
GR (1) GR3002230T3 (de)
NZ (1) NZ227930A (de)
PT (1) PT89677A (de)
ZA (1) ZA891052B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2017932B3 (es) * 1985-12-23 1991-03-16 Dr Lo Zambeletti S P A Compuestos azaciclicos, procedimientos de su preparacion y su uso como farmacos.
US5512567A (en) * 1988-08-24 1996-04-30 Sankyo Company, Limited Analgesic compounds, their preparation, and pharmaceutical compositions containing them
EP0361791B1 (de) * 1988-09-26 1995-11-08 Smithkline Beecham Farmaceutici S.p.A. Azacyclische Verbindungen, verwendbar als Arzneimittel
GB8926560D0 (en) * 1989-11-24 1990-01-17 Zambeletti Spa L Pharmaceuticals
EP0447704A1 (de) * 1990-03-21 1991-09-25 Smithkline Beecham Farmaceutici S.p.A. N-Acylierte azyklische Verbindungen, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel
EP0594611A1 (de) * 1990-04-28 1994-05-04 Dr. Lo. Zambeletti S.p.A. Neue 1-[2h-1-oxo-3,4-dihydronaphthyl-g]-acetyl-piperdine, herstellungsverfahren und therapeutische anwendung
GB9011656D0 (en) * 1990-05-24 1990-07-11 Zambeletti Spa L Novel compounds
AU2002322720B2 (en) 2001-07-25 2008-11-13 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
WO2006116718A2 (en) 2005-04-28 2006-11-02 Proteus Biomedical, Inc. Pharma-informatics system
JP2010503710A (ja) 2006-09-18 2010-02-04 ラプトール ファーマシューティカル インコーポレイテッド 受容体関連タンパク質(rap)結合体の投与による肝障害の処置
ES2919563T3 (es) 2009-02-20 2022-07-27 Enhanx Biopharm Inc Sistema de administración de medicamentos a base de glutatión
EA024559B1 (ru) 2009-05-06 2016-09-30 Лаборэтори Скин Кэа, Инк. Композиции для нанесения на кератинизированную поверхность кожи млекопитающего и способ доставки
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CN105299030B (zh) * 2015-11-23 2018-03-23 荣腾实业(苏州)有限公司 一种驱动轴导向机构

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0052311A1 (de) * 1980-11-19 1982-05-26 Sterling Drug Inc. 1-(Benzoylphenyl-niederalkyl)-piperidine und entsprechende Carbinole und ihre Herstellung
US4656182A (en) * 1983-12-06 1987-04-07 Warner-Lambert Company Substituted trans-1,2-diaminocyclohexyl amide compounds
DE3409237A1 (de) * 1984-03-14 1985-09-19 Dr. Karl Thomae Gmbh, 7950 Biberach Kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
ES2017932B3 (es) * 1985-12-23 1991-03-16 Dr Lo Zambeletti S P A Compuestos azaciclicos, procedimientos de su preparacion y su uso como farmacos.
EP0249349B1 (de) * 1986-06-05 1992-10-14 Ici Americas Inc. Difluorketoverbindungen
EP0260041B1 (de) * 1986-09-02 1991-01-30 Dr. Lo. Zambeletti S.p.A. 1-Acylsubstituierte Piperidinderivate
NZ223017A (en) * 1986-12-22 1990-07-26 Zambeletti Spa L Piperidine derivatives and analgesics

Also Published As

Publication number Publication date
KR890012963A (ko) 1989-09-20
DK65489D0 (da) 1989-02-10
DE68900113D1 (de) 1991-07-18
ATE64391T1 (de) 1991-06-15
AU2983489A (en) 1989-08-17
GB8803259D0 (en) 1988-03-09
EP0333315A1 (de) 1989-09-20
JPH01246258A (ja) 1989-10-02
PT89677A (pt) 1989-10-04
DK65489A (da) 1989-08-13
NZ227930A (en) 1992-05-26
EP0333315B1 (de) 1991-06-12
GR3002230T3 (en) 1992-12-30
US4994450A (en) 1991-02-19
AU615984B2 (en) 1991-10-17
ES2039845T3 (es) 1993-10-01

Similar Documents

Publication Publication Date Title
ZA891052B (en) Novel compounds
ZA88266B (en) Novel treatment
MX9301457A (es) Agentes antifungicos de peptidos ciclicos y proceso para su preparacion.
FI932445A (fi) Farmaceutiska foereningar
NZ228331A (en) Amine- and amido-containing heterocyclic compounds and pharmaceutical compositions
GR3027694T3 (en) Naphthyloxyacetic acid derivatives as PGE2 agonists and antagonists.
TW252918B (de)
DE68910999D1 (de) 1,2,3,4-Tetrahydroisoquinoline, Verfharen zu ihrer Herstellung und ihre Verwendung als Kappa-Rezeptor Agonisten.
GB8916395D0 (en) Pharmaceuticals
SE8401398D0 (sv) 7-oxabicykloheptansubstituerade prostaglandinanaloger
PL287073A1 (en) Method of obtaining novel derivatives of benzanilide
EP0555479A4 (de)
DE3872817D1 (en) Oximinaetherderivate.
ES2002381A6 (es) Un procedimiento para preparar derivados de naftaleno
SE8503054D0 (sv) Catecholcarboxamides
DK502183D0 (da) Ureaderivater med herbicid virkning
DE3470882D1 (en) N-substituted tetrahydrothiazines, process for their preparation, and their use as pesticides
GR69209B (de)